Details for New Drug Application (NDA): 203322
✉ Email this page to a colleague
The generic ingredient in SUMATRIPTAN SUCCINATE is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
Summary for 203322
Tradename: | SUMATRIPTAN SUCCINATE |
Applicant: | Norvium Bioscience |
Ingredient: | sumatriptan succinate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | ||||
Approval Date: | Apr 14, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription